Amgen Inc. - AMGN

AMGN Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
AMGN	0.1	-0.4	-12.8	-15.8	-9.5	2.1	37.5	19.6	65.6	80865.8
S&P 500	0.0	0.8	5.6	9.4	14.5	32.4	33.3	95.6	191.7	34157.5

Compare AMGN with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	AMGN
name	Amgen Inc.
price	278.32
changes percentage	0.08
change	0.22
day low	276.50
day high	281.38
year high	346.85
year low	257.80
market cap	149606184560
price avg 50	311.33
price avg 200	305.69
exchange	NASDAQ
volume	5077011
avg volume	2642403
open	277
previous close	278.10
eps	7.84
pe	35.50
earnings announcement	2025-02-04T05:00:00.000+0000
shares outstanding	537533000
timestamp	2024-12-03 21:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 56.7%

Overall Quarterly Financial Health: 77.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000318154
revenue	28190000000	26323000000	7.09
gross profit	19775000000	19917000000	-0.71
gross profit ratio	0.7	0.76	-7.29
research and development expenses	4784000000	4434000000	7.89
operating expenses	11878000000	10351000000	14.75
interest income	0	1406000000	-100.00
interest expense	2875000000	1406000000	104.48
ebitda	14702000000	12093000000	21.57
ebitdaratio	0.52	0.33	56.86
operating income	7897000000	5335000000	48.02
operating income ratio	0.28	0.2	38.22
net income	6717000000	6552000000	2.52
net income ratio	0.24	0.25	-4.27
eps	12.56	12.18	3.12

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 28,190 million in 2023 from 26,323 million in 2022 representing a change of 7.09%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 4,784 million in 2023 from 4,434 million in 2022 representing a change of 7.89%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 14,702 million in 2023 from 12,093 million in 2022 representing a change of 21.57%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 7,897 million in 2023 from 5,335 million in 2022 representing a change of 48.02%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 6,717 million in 2023 from 6,552 million in 2022 representing a change of 2.52%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 12.56 in 2023 from 12.56 in 2022 representing a change of 3.12%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 19,775 million in 2023 from 19,917 million in 2022 representing a change of -0.71%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 11,878 million in 2023 from 10,351 million in 2022 representing a change of 14.75%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000318154
revenue	8503000000	8333000000	2.04
gross profit	5193000000	5097000000	1.88
gross profit ratio	0.61	0.61	-0.15
research and development expenses	1450000000	1447000000	0.21
operating expenses	3146000000	3243000000	-2.99
interest income	0	0	NaN
interest expense	776000000	808000000	-3.96
ebitda	5288000000	3322000000	59.18
ebitdaratio	0.62	0.39	59.26
operating income	2047000000	1854000000	10.41
operating income ratio	0.24	0.22	8.20
net income	2830000000	746000000	279.36
net income ratio	0.33	0.09	271.77
eps	5.27	1.39	279.14

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 8,503 million in 2024Q3 from 8,333 million in 2024Q2 representing a change of 2.04%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 5,193 million in 2024Q3 from 5,097 million in 2024Q2 representing a change of 1.88%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 1,450 million in 2024Q3 from 1,447 million in 2024Q2 representing a change of 0.21%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 3,146 million in 2024Q3 from 3,243 million in 2024Q2 representing a change of -2.99%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 5,288 million in 2024Q3 from 3,322 million in 2024Q2 representing a change of 59.18%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 2,047 million in 2024Q3 from 1,854 million in 2024Q2 representing a change of 10.41%. The increase in operating income indicates better operational performance and increased profitability.

  Earnings per Share (EPS): EPS increased to 5.27 in 2024Q3 from 5.27 in 2024Q2 representing a change of 279.14%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Net Income: Net income decreased to 2,830 million in 2024Q3 from 746 million in 2024Q2 representing a change of 279.36%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000318154
total assets	97154000000	65121000000	49.19
total liabilities	90922000000	61460000000	47.94
total equity	6232000000	3661000000	70.23
cash and cash equivalents	10944000000	7629000000	43.45
short term investments	10944000000	1676000000	552.98
long term investments	0	3503000000	-100.00
total current assets	30332000000	22186000000	36.72
total non current assets	66822000000	42935000000	55.64
total current liabilities	18392000000	15687000000	17.24
total non current liabilities	72530000000	45773000000	58.46
common stock	33070000000	32514000000	1.71
retained earnings	-26549000000	-28622000000	7.24
total debt	64613000000	38945000000	65.91

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 97,154 million in 2023 from 65,121 million in 2022 representing a change of 49.19%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 6,232 million in 2023 from 3,661 million in 2022 representing a change of 70.23%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 10,944 million in 2023 from 7,629 million in 2022 representing a change of 43.45%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 10,944 million in 2023 from 1,676 million in 2022 representing a change of 552.98%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 30,332 million in 2023 from 22,186 million in 2022 representing a change of 36.72%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 33,070 in 2023 from 32,514 in 2022 representing a change of 1.71%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -26,549 million in 2023 from -28,622 million in 2022 representing a change of 7.24%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 90,922 million in 2023 from 61,460 million in 2022 representing a change of 47.94%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 18,392 million in 2023 from 15,687 million in 2022 representing a change of 17.24%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 64,613 million in 2023 from 38,945 million in 2022 representing a change of 65.91%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000318154
total assets	90883000000	90907000000	-0.03
total liabilities	83356000000	84982000000	-1.91
total equity	7527000000	5925000000	27.04
cash and cash equivalents	9011000000	9301000000	-3.12
short term investments	0	0	NaN
long term investments	688000000	1162000000	-40.79
total current assets	26766000000	27206000000	-1.62
total non current assets	64117000000	63701000000	0.65
total current liabilities	20312000000	21517000000	-5.60
total non current liabilities	63044000000	63465000000	-0.66
common stock	33393000000	33204000000	0.57
retained earnings	-25530000000	-27124000000	5.88
total debt	60398000000	62645000000	-3.59

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 90,883 million in 2024Q3 from 90,907 million in 2024Q2 representing a change of -0.03%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 9,011 million in 2024Q3 from 9,301 million in 2024Q2 representing a change of -3.12%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 26,766 million in 2024Q3 from 27,206 million in 2024Q2 representing a change of -1.62%. This indicates a worsen liquidity position.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 83,356 million in 2024Q3 from 84,982 million in 2024Q2 representing a change of -1.91%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 7,527 million in 2024Q3 from 5,925 million in 2024Q2 representing a change of 27.04%. This indicates an increase in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities decreased to 20,312 million in 2024Q3 from 21,517 million in 2024Q2 representing a change of -5.6%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 33,393 in 2024Q3 from 33,204 in 2024Q2 representing a change of 0.57%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -25,530 million in 2024Q3 from -27,124 million in 2024Q2 representing a change of 5.88%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 60,398 million in 2024Q3 from 62,645 million in 2024Q2 representing a change of -3.59%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000318154
net change in cash	3315000000	-360000000	1,020.83
operating cash flow	8471000000	9721000000	-12.86
free cash flow	7359000000	8785000000	-16.23
capital expenditure	-1112000000	-936000000	-18.80
depreciation and amortization	4071000000	3417000000	19.14
deferred income tax	-1273000000	-1198000000	-6.26
stock based compensation	431000000	401000000	7.48
accounts payables	-402000000	154000000	-361.04
inventory	491000000	-742000000	166.17
acquisitions net	-26989000000	-3727000000	-624.15
investments in property plant and equipment	-1112000000	-936000000	-18.80
net cash used for investing activites	-26204000000	-6044000000	-333.55
debt repayment	25676000000	6622000000	287.74
common stock issued	0	0	NaN
common stock repurchased	0	-6360000000	100.00
dividends paid	-4556000000	-4196000000	-8.58
net cash used provided by financing activities	21048000000	-4037000000	621.38
cash at end of period	10944000000	7629000000	43.45
accounts receivables	0	-746000000	100.00
cash at beginning of period	7629000000	7989000000	-4.51

Overall Score of Annual Cashflow Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 3,315 million in 2023 from -360 million in 2022 representing a change of 1020.83%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -1,112 million in 2023 from -936 million in 2022 representing a change of -18.8%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 8,471 million in 2023 from 9,721 million in 2022 representing a change of -12.86%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 7,359 million in 2023 from 8,785 million in 2022 representing a change of -16.23%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation increased to 431 million in 2023 from 401 million in 2022 representing a change of 7.48%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 402 million in 2023 from 154 million in 2022 representing a change of -361.04%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 0 in 2023 from -746 million in 2022 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -4,556 million in 2023 from -4,196 million in 2022 representing a change of -8.58%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000318154
operating cash flow	3571000000	2459000000	45.22
free cash flow	3314000000	2221000000	49.21
capital expenditure	-257000000	-238000000	-7.98
depreciation and amortization	1396000000	1400000000	-0.29
deferred income tax	-110000000	-383000000	71.28
stock based compensation	136000000	157000000	-13.38
accounts receivables	-342000000	-176000000	-94.32
accounts payables	-122000000	643000000	-118.97
inventory	681000000	722000000	-5.68
acquisitions net	0	0	NaN
investments in property plant and equipment	-257000000	-238000000	-7.98
net cash used for investing activites	-210000000	-217000000	3.23
debt repayment	-2200000000	-1400000000	-57.14
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-1210000000	-1209000000	-0.08
net cash used provided by financing activities	-3651000000	-2649000000	-37.83
net change in cash	-290000000	-407000000	28.75
cash at end of period	9011000000	9301000000	-3.12
cash at beginning of period	9301000000	9708000000	-4.19

Overall Score of Quarterly Cashflow Statement

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -290 million in 2024Q3 from -407 million in 2024Q2 representing a change of 28.75%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 3,571 million in 2024Q3 from 2,459 million in 2024Q2 representing a change of 45.22%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 3,314 million in 2024Q3 from 2,221 million in 2024Q2 representing a change of 49.21%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -257 million in 2024Q3 from -238 million in 2024Q2 representing a change of -7.98%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 136 million in 2024Q3 from 157 million in 2024Q2 representing a change of -13.38%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 122 million in 2024Q3 from 643 million in 2024Q2 representing a change of -118.97%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to -342 million in 2024Q3 from -176 million in 2024Q2 representing a change of -94.32%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to -110 million in 2024Q3 from -383 million in 2024Q2 representing a change of 71.28%. This indicates that the company's tax liability for future periods has increased.

  Dividends Paid: Dividends Paid decreased to -1,210 million in 2024Q3 from -1,209 million in 2024Q2 representing a change of -0.08%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	52.69	48.93	7.69
net income per share	12.56	12.18	3.09
operating cash flow per share	15.83	18.07	-12.37
free cash flow per share	13.76	16.33	-15.76
cash per share	40.91	17.3	136.55
book value per share	11.65	6.8	71.18
tangible book value per share	-84.18	-51.95	-62.05
shareholders equity per share	11.65	6.8	71.18
interest debt per share	126.15	75.0	68.19
market cap	154090700000	141300320000	9.05
enterprise value	207759700000	172616320000	20.36
pe ratio	22.94	21.57	6.37
price to sales ratio	5.47	5.37	1.83
pocfratio	18.19	14.54	25.14
pfcf ratio	20.94	16.08	30.18
pb ratio	24.73	38.6	-35.94
ptb ratio	24.73	38.6	-35.94
ev to sales	7.37	6.56	12.39
enterprise value over ebitda	14.13	14.27	-1.00
ev to operating cash flow	24.53	17.76	38.12
ev to free cash flow	28.23	19.65	43.68
earnings yield	0.04	0.05	-5.99
free cash flow yield	0.05	0.06	-23.19
debt to equity	10.37	10.64	-2.54
debt to assets	0.67	0.6	11.21
net debt to ebitda	3.65	2.59	40.97
current ratio	1.65	1.41	16.61
interest coverage	2.75	3.79	-27.61
income quality	1.26	1.48	-15.00
dividend yield	0.03	0.03	-0.43
payout ratio	0.68	0.64	5.91
sales general and administrative to revenue	0.2	0.17	12.69
research and ddevelopement to revenue	0.17	0.17	0.75
intangibles to total assets	0.53	0.49	8.72
capex to operating cash flow	0.13	0.1	36.33
capex to revenue	0.04	0.04	10.94
capex to depreciation	0.27	0.27	-0.28
stock based compensation to revenue	0.02	0.02	0.36
graham number	57.36	43.18	32.84
roic	0.1	0.11	-14.65
return on tangible assets	0.15	0.2	-25.12
graham net net	-109.01	-84.61	-28.84
working capital	11940000000	6499000000	83.72
tangible asset value	-45038000000	-27948000000	-61.15
net current asset value	-60590000000	-39274000000	-54.28
invested capital	69802000000	43535000000	60.34
average receivables	6752500000	5229000000	29.14
average payables	1581000000	1469000000	7.62
average inventory	7224000000	4508000000	60.25
days sales outstanding	102.83	77.14	33.31
days payables outstanding	68.97	89.57	-23.00
days of inventory on hand	412.84	280.9	46.97
receivables turnover	3.55	4.73	-24.99
payables turnover	5.29	4.08	29.87
inventory turnover	0.88	1.3	-31.96
roe	1.08	1.79	-39.78
capex per share	2.08	1.74	19.47

• Neutral

  ROE: Return on Equity (ROE) decreased to 1.08 on 2023-12-31 from 1.79 on 2022-12-31, representing a change of -39.78%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 22.94 on 2023-12-31 from 21.57 on 2022-12-31, representing a change of 6.37%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.65 on 2023-12-31 from 1.41 on 2022-12-31, representing a change of 16.61%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Negative

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 10.37 on 2023-12-31 from 10.64 on 2022-12-31, representing a change of -2.54%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. However, a ratio of 2.0 or higher is usually considered risky.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
AMGN
calendar year	2024	2024	NaN
revenue per share	15.83	15.52	2.04
net income per share	5.27	1.39	279.36
operating cash flow per share	6.65	4.58	45.22
free cash flow per share	6.17	4.14	49.21
cash per share	16.78	17.32	-3.12
book value per share	14.02	11.03	27.04
tangible book value per share	-74.58	-79.82	6.56
shareholders equity per share	14.02	11.03	27.04
interest debt per share	113.92	118.16	-3.59
market cap	173026770000	167012370000	3.60
enterprise value	224413770000	220356370000	1.84
pe ratio	15.29	55.97	-72.69
price to sales ratio	20.35	20.04	1.53
pocfratio	48.45	67.92	-28.66
pfcf ratio	52.21	75.2	-30.57
pb ratio	22.99	28.19	-18.45
ptb ratio	22.99	28.19	-18.45
ev to sales	26.39	26.44	-0.19
enterprise value over ebitda	42.44	66.33	-36.02
ev to operating cash flow	62.84	89.61	-29.87
ev to free cash flow	67.72	99.21	-31.75
earnings yield	0.02	0.0	266.17
free cash flow yield	0.02	0.01	44.03
debt to equity	8.02	10.57	-24.11
debt to assets	0.66	0.69	-3.56
net debt to ebitda	9.72	16.06	-39.48
current ratio	1.32	1.26	4.22
interest coverage	2.64	2.29	14.96
income quality	1.26	3.3	-61.72
dividend yield	0.01	0.01	-3.40
payout ratio	0.43	1.62	-73.62
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.17	0.17	-1.80
intangibles to total assets	0.52	0.54	-2.45
capex to operating cash flow	0.07	0.1	-25.64
capex to revenue	0.03	0.03	5.82
capex to depreciation	0.18	0.17	8.29
stock based compensation to revenue	0.02	0.02	-15.11
graham number	40.77	18.57	119.53
roic	0.03	0.03	8.26
return on tangible assets	0.07	0.02	268.97
graham net net	-121.37	-123.8	1.97
working capital	6454000000	5689000000	13.45
tangible asset value	-40051000000	-42863000000	6.56
net current asset value	-56590000000	-57776000000	2.05
invested capital	60188000000	60574000000	-0.64
average receivables	7125500000	6855000000	3.95
average payables	2207000000	1947500000	13.32
average inventory	7678500000	8359500000	-8.15
days sales outstanding	77.45	74.89	3.41
days payables outstanding	58.38	63.05	-7.41
days of inventory on hand	200.18	222.36	-9.98
receivables turnover	1.16	1.2	-3.30
payables turnover	1.54	1.43	8.00
inventory turnover	0.45	0.4	11.08
roe	0.38	0.13	198.62
capex per share	0.48	0.44	7.98

• Positive

  ROE: Return on Equity (ROE) increased to 0.38 on 2024-09-30 Q3 from 0.13 on 2024-06-30 Q2, representing a change of 198.62%. Suggesting the company has been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 1.32 on 2024-09-30 Q3 from 1.26 on 2024-06-30 Q2, representing a change of 4.22%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 15.29 on 2024-09-30 Q3 from 55.97 on 2024-06-30 Q2, representing a change of -72.69%. Indicating a decrease in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 8.02 on 2024-09-30 Q3 from 10.57 on 2024-06-30 Q2, representing a change of -24.11%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. However, a ratio of 2.0 or higher is usually considered risky.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 553.89 which is higher than current price 278.32, indicates the company may be undervalued.